<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200818048445N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-28</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>A Comparison between the sedative effect of Fentanyl and Ketamine outside the operating room.</public_title>
      <acronym></acronym>
      <scientific_title>A Comparison between the effect of Propofol Fentanyl and Propofol Ketamine on Colonoscopy patients' sedation.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-18</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>144</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50428</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Subjects were randomly divided into two groups based on the method of four random blocks.The site www.sealedenvelope.com was used for randomization.If we call the two groups A and B, the logic of randomization is that we select as many samples from the 6 blocks, AABB, BAAB, BBAA, ABBA, ABAB and BABA, by (ie as n / 4)by placing them to reach the sample size, Blinding description: In order to double blind the study, the patient's degree of sedation is recorded according to a modified Ramsay standard during the procedure by another person who does not know the medication prescribed to the patient.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Pain management of patients referred for Colonoscopy and reduce their anxiety.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: The group receiving Propofol Fentanyl for sedation during Colonoscopy. Intervention 2: Intervention group 2: The group receiving Propofol Ketamine for sedation during Colonoscopy.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The Excel file contains the identification code, reference to the file number and the registered information, except for the documents that can be provided.

When:
6 months after printing the results until 10 years later

To whom:
All those who officially correspond with the Vice Chancellor for Research of Ahvaz Jundishapur University of Medical Sciences

Conditions:
Documents can be used for systematic review studies and meta-analysis

Where to obtain:
Vice Chancellor for Research Ahvaz Jundishapur University

How to obtain:
After approval from the Vice Chancellor for Research, the data file will be provided to the Vice Chancellor and then the data will be shared with other researchers or emailed to them.

Comments:
The material and intellectual property of this project is with Ahvaz University of Medical Sciences</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Baghbanian reza</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.123/1, 3d Phase, West Mordad St, Chamran Blvd, Kian Pars</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6155644379</zip>
        <telephone>+98 61 3376 5834</telephone>
        <email>hosseinpour.m@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Baghbanian reza</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.123/1, West Mordad Ave, Chamran Blvd, Kiyan Pars</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6155644379</zip>
        <telephone>+98 61 3376 5834</telephone>
        <email>baghbanian-r@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>They are between 18 and 65 years old
Patients are referred for colonoscopy procedure
Classification of Group 1 and 2 American Society of Anesthesiologists (ASA Class I &amp; II) are selected as inclusion criteria.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>the patient's unwillingness to participate in the study
They are under 18 years old
They are over 65 years old
They have kidney failure
They have liver failure
They have chronic pain syndrome
They are addicted
They have any drug allergies
They have cardiovascular disease
They have a respiratory disease
They have metabolic diseases
They have a neurological disease
They have difficult airways
The patient is classified as ASA class 3 and 4
Contraindicated propofol ketamine or propofol fentanyl</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: The group receiving Propofol Fentanyl for sedation during Colonoscopy.</i_keyword>
      <i_keyword>Intervention group 2: The group receiving Propofol Ketamine for sedation during Colonoscopy.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>A score of 5 or 6 RAMSAY criteria in the questionnaire. RAMSAY sedation criteria including 6 scores is as follows: 1. Completely awake and anxious 2. Quiet and calm with enough cooperation 3. Asleep and wakes up with a verbal command 4. Asleep and woke up with mild stimulation, but gives a strong reaction to painful stimuli  5. Slow reaction to painful stimuli 6. Lack of reaction to painful stimuli. Timepoint: 5 minutes after the procedure, 10 minutes after the procedure, 15 minutes after the procedure. Method of measurement: Verbal measurement criteria.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The amount of pain. Timepoint: Start of procedure , end of procedure and one hour after the end of the procedure. Method of measurement: The Ambesh criterion, which includes the following four-point grading questions: 1. No pain: Negative answer to questions about having pain 2. Mild: Positive answers to questions about having pain, but without any physical symptoms 3. Medium: Positive answers to questions about having pain and the appearance of physical symptoms or successive complaints of pain 4. Intensity: The patient verbally complains of severe pain or shows pain with frowning and upset in the face or turning away with hand or expressing fear.</sec_outcome>
      <sec_outcome>Recovery time. Timepoint: Recovery time is defined as fast (less than 5 minutes), medium (between 5 to 10 minutes) and slow (more than 15 minutes). Method of measurement: Patient's appropriate answers to questions.</sec_outcome>
      <sec_outcome>Nausea. Timepoint: Every 5 minutes. Method of measurement: It is expressed by the person herself/himself.</sec_outcome>
      <sec_outcome>Systolic blood pressure. Timepoint: Every 5 minutes. Method of measurement: Blood pressure monitor.</sec_outcome>
      <sec_outcome>Diastolic blood pressure. Timepoint: Every 5 minutes. Method of measurement: Blood pressure monitor.</sec_outcome>
      <sec_outcome>Heart beat. Timepoint: every 5 minutes. Method of measurement: Cardiac monitor.</sec_outcome>
      <sec_outcome>Arterial blood oxygen saturation. Timepoint: Every 5 minutes. Method of measurement: Respiratory monitor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-13</approval_date>
        <contact_name>Research Ethics Committee of Ahwaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Golestan Hospital, Golestan BLVD Ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
